D09.3
D09.3 — Carcinoma in situ of thyroid and other endocrine glands
Billable / specific codeICD-10-CM
D09.3 is a billable, specific ICD-10-CM code for carcinoma in situ of thyroid and other endocrine glands. It is valid for submission on a claim.
Risk adjustment
D09.3 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
D09.3 is named in 16 Medicare coverage policies — 16 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A56580Billing and Coding: Computerized Axial Tomography (CT), Thorax
- A56695Billing and Coding: Implantable Infusion Pump
Related codes at this level
Codes that share D09. If D09.3 is not quite right, the correct code is usually one of these.
Questions about D09.3
- Is D09.3 a billable ICD-10-CM code?
- Yes. D09.3 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does D09.3 sit in the tabular list?
- Neoplasms (C00-D49), in the block In situ neoplasms (D00-D09).
- What cannot be coded together with D09.3?
- D09.3 carries an Excludes1 note, which means the conditions it lists can never be coded together with it on the same encounter.